Vous avez cherché: kalciumbaserede (Danois - Anglais)

doser på basis af mg- vægten sammenlignet med patientens tidligere kalciumbaserede fosfatbindende middel.
if renagel is prescribed as an alternative phosphate binder, renagel should be given in equivalent doses on a mg weight basis compared to the patient’ s previous calcium based phosphate binder.

sevelamer indeholder ikke kalcium og reducerer incidensen af episoder med hyperkalcæmi sammenlignet med patienter, der kun tager kalciumbaserede phosphatbindere.
sevelamer does not contain calcium and decreases the incidence of hypercalcaemic episodes as compared to patients using calcium based phosphate binders alone.

middel, skal renagel gives i ækvivalente doser på basis af mg-vægten sammenlignet med patientens tidligere kalciumbaserede fosfatbindende middel.
if renagel is prescribed as an alternative phosphate binder, renagel should be given in equivalent doses on a mg weight basis compared to the patient 's previous calcium based phosphate binder.

en forværring af acidose er indberettet efter skifte fra andre fosfatbindere til sevelamer i en række undersøgelser, hvor der blev observeret lavere bikarbonatniveauer hos patienter, der blev behandlet med sevelamer, sammenlignet med patienter, der blev behandlet med kalciumbaserede bindere.
worsening of acidosis has been reported upon switching from other phosphate binders to sevelamer in a number of studies where lower bicarbonate levels in the sevelamer-treated patients compared to patients treated with calcium-based binders were observed.

patienter, der tidligere har taget phosphatbindere (sevelamerhydrochlorid eller kalciumbaseret), bør indgives sevelamer carbonate zentiva på gram til gram basis under overvågning af serumphosphatniveauet for at sikre en optimal daglig dosis.
for patients previously on phosphate binders (sevelamer hydrochloride or calcium based), sevelamer carbonate zentiva should be given on a gram for gram basis with monitoring of serum phosphorus levels to ensure optimal daily doses.